XRCC1 and posterior cortical atrophy: The IC50 value of olaparib and talazoparib in different PCa cell models with varying XRCC1 protein levels and our doxycycline-inducible system provides evidence of a tight inverse correlation between XRCC1 expression level and PARPi sensitivity.